A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Phase 1/2 Recruiting
182 enrolled
MK-5684-01A
Phase 1/2 Recruiting
220 enrolled
MK-2140-010
Phase 3 Recruiting
1,046 enrolled
MK-2400-001
Phase 3 Recruiting
1,440 enrolled
KLK2-PASenger
Phase 3 Recruiting
800 enrolled
OLYMPIA-1
Phase 3 Recruiting
822 enrolled
OMAHA-003
Phase 3 Recruiting
1,310 enrolled
MK-5684-004
Phase 3 Recruiting
1,314 enrolled
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Phase 2 Recruiting
496 enrolled
EPCOREâ„¢FL-2
Phase 3 Recruiting
1,095 enrolled
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Phase 2 Recruiting
218 enrolled
A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
Phase 1 Recruiting
12 enrolled
KEYNOTE-365
Phase 1/2 Recruiting
1,200 enrolled
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
Phase 1 Recruiting
277 enrolled
Soundtrack-E
Phase 1/2 Recruiting
276 enrolled
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 Recruiting
174 enrolled
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Phase 1 Recruiting
174 enrolled
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Phase 1/2 Recruiting
100 enrolled
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 Recruiting
900 enrolled
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Phase 3 Recruiting
400 enrolled
CRESCENDO
Phase 3 Recruiting
504 enrolled
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Phase 3 Recruiting
224 enrolled
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
Phase 1/2 Recruiting
66 enrolled
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Phase 1/2 Recruiting
97 enrolled
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
Phase 1 Recruiting
480 enrolled
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Phase 2 Recruiting
582 enrolled
Phase Ib Study of Rocbrutinib in Combination with R-CHOP in Patients with Newly Diagnosed B-cell Non-Hodgkin Lymphoma
Phase 1 Recruiting
112 enrolled